Nisa Investment Advisors
OMGA

Nisa Investment Advisors’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Nisa Investment Advisors’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25
Closed -$52 – 3065
2024
Q2 		$52 Buy
25
+8
+47% +$19 ﹤0.01% 2904
2024
Q1 		$62 Buy
+17
New +$65 ﹤0.01% 2737
2023
Q4 		– Sell
-31
Closed -$67 – 2775
2023
Q3 		$67 Buy
+31
New +$124 ﹤0.01% 2761

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nisa Investment Advisors's OMGA Position: Q3 2024 in Review

Nisa Investment Advisors sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q3 2024, closing a stake of 25 shares — an estimated $52 sold.

Nisa Investment Advisors first reported a position in OMGA in Q3 2023 and held it in 3 quarters. The position peaked at $67 in Q3 2023. 54 funds tracked by Wall St. Rank hold OMGA as of Q3 2024.

  • Nisa Investment Advisors reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Nisa Investment Advisors sold 25 Omega Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $52.
  • Nisa Investment Advisors first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
  • Nisa Investment Advisors's Omega Therapeutics, Inc. Common Stock position peaked at $67 in Q3 2023.
  • 54 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Nisa Investment Advisors's 13F filing for Q3 2024, filed 24 Oct 2024.